Cronos Group Inc. - Common Share (CRON): Price and Financial Metrics

CRON POWR Grades

• CRON scores best on the Growth dimension, with a Growth rank ahead of 58.08% of US stocks.
• The strongest trend for CRON is in Value, which has been heading up over the past 179 days.
• CRON ranks lowest in Momentum; there it ranks in the 0th percentile.

CRON Stock Summary

• The ratio of debt to operating expenses for CRONOS GROUP INC is higher than it is for about merely 4.98% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.04 for CRONOS GROUP INC; that's greater than it is for merely 7.06% of US stocks.
• With a year-over-year growth in debt of -43.12%, CRONOS GROUP INC's debt growth rate surpasses just 6.95% of about US stocks.
• If you're looking for stocks that are quantitatively similar to CRONOS GROUP INC, a group of peers worth examining would be FTHM, OGI, VEEE, AMRN, and LIQT.
• Visit CRON's SEC page to see the company's official filings. To visit the company's web site, go to www.thecronosgroup.com.

CRON Valuation Summary

• CRON's EV/EBIT ratio is -2; this is 116.67% lower than that of the median Healthcare stock.
• CRON's price/sales ratio has moved down 2663.3 over the prior 64 months.

Below are key valuation metrics over time for CRON.

CRON Growth Metrics

Its 3 year price growth rate is now at -77.43%.
• The 2 year net cashflow from operations growth rate now stands at 8.48%.
• Its 4 year net income to common stockholders growth rate is now at 47579.27%.

Over the past 27 months, CRON's revenue has gone up $63,690,639.

The table below shows CRON's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	94.812	-100.514	-223.487
2022-06-30	94.296	-118.61	-108.58
2022-03-31	86.857	-141.525	-267.433
2021-12-31	74.435	-153.616	-396.107
2021-09-30	65.686	-155.451	-373.703
2021-06-30	56.637	-151.461	-146.458

CRON's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRON has a Quality Grade of F, ranking ahead of 0.86% of graded US stocks.
• CRON's asset turnover comes in at 0.03 -- ranking 353rd of 682 Pharmaceutical Products stocks.
• 500 - Internal server error

The table below shows CRON's key quality metrics over time.